Measles Vaccine Wipes Out Incurable Cancer in Landmark Mayo Clinic Study
Multiple Myeloma Patient in Full Remission After Massive Dose of Measles
Category: Research
Global Burden of Asbestos Still Growing with Life Years Lost to Mesothelioma
Between 1994 and 2010, more than 2.1 million years of human life were lost to malignant mesothelioma, according to the latest research from Japan.
Statin Drugs Show Potential as Possible Treatment for Mesothelioma
Statin drugs show potential as therapy in future mesothelioma treatment, according to new research from Japan.
Specialized Care for Mesothelioma Reaches Elite Level at Moffitt Cancer Center
Advancement of mesothelioma treatment has made specialized care at Moffitt Cancer Center in Tampa more important than ever.
Researchers at NYU Identify Problematic Protein in Mesothelioma Tumor Growth
Researchers at New York University Langone Medical Center have uncovered a possible treatment target for mesothelioma.
Tampa’s Moffitt Cancer Center Takes Leadership Role in Treatment of Mesothelioma
Patients in the southeast United States no longer must travel to Boston, New York or Houston to get the latest and greatest treatment for mesothelioma.
Three Women Spark July 4 Miles for Meso Fundraising Event
Three women in Federal Way, Wash., sparked the July 4 Miles for Meso event.
Smoking Cessation for Asbestos Workers Dramatically Reduces Lung Cancer Risk
Smoking cessation can be critical to reducing future lung cancer risk for asbestos workers.
Lung Cancer Treatment May Improve with New Chemotherapy Delivery System
Recent research shows that a new delivery method can make chemotherapy more effective for lung cancer and possibly mesothelioma.
New Immunotherapy Drug Works with Lung Cancer, Might Be Future for Mesothelioma Treatment
An Immunotherapy drug testing well with lung cancer has become a future hope for mesothelioma treatment.
Mesothelioma Incidence Rates Remain Steady Despite Dramatic Decline in Asbestos Use
The use of asbestos has been reduced dramatically, but mesothelioma incidence rates still on steady course.